Up-Regulation of circEIF6 Contributes to Pancreatic Cancer Development Through Targeting miR-557/SLC7A11/PI3K/AKT Signaling

References

• Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388(10039):73–85. doi:10.1016/S0140-6736(16)00141-026830752
   PubMed Web of Science ®Google Scholar
• Marchesi F, Piemonti L, Mantovani A, Allavena P. Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis. Cytokine Growth Factor Rev. 2010;21(1):77–82. doi:10.1016/j.cytogfr.2009.11.00120060768
   PubMed Web of Science ®Google Scholar
• McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24(43):4846–4861. doi:10.3748/wjg.v24.i43.484630487695
   PubMed Web of Science ®Google Scholar
• Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1):94.28535767
   PubMed Web of Science ®Google Scholar
• Gao JL, Chen G, He HQ, Wang J. [CircRNA as a new field in human disease research]. Zhongguo Zhong Yao Za Zhi. 2018;43(3):457–462.29600608
   PubMedGoogle Scholar
• Kristensen LS, Hansen TB, Venø MT, Kjems J. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–565.28991235
   PubMed Web of Science ®Google Scholar
• Zhang HD, Jiang LH, Sun DW, Hou JC, Ji ZL. CircRNA: a novel type of biomarker for cancer. Breast Cancer. 2018;25(1):1–7.28721656
   PubMed Web of Science ®Google Scholar
• Li H, Hao X, Wang H, et al. Circular RNA expression profile of pancreatic ductal adenocarcinoma revealed by microarray. Cell Physiol Biochem. 2016;40(6):1334–1344.27997903
   PubMed Web of Science ®Google Scholar
• Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272–283.27040487
   PubMed Web of Science ®Google Scholar
• Qadir MI, Faheem A. miRNA: A diagnostic and therapeutic tool for pancreatic cancer. Crit Rev Eukaryot Gene Expr. 2017;27(3):197–204. doi:10.1615/CritRevEukaryotGeneExpr.201701949429199604
   PubMed Web of Science ®Google Scholar
• Wang J, Wang B, Ren H, Chen W. miR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1. Biochem Biophys Res Commun. 2019;509(1):241–248. doi:10.1016/j.bbrc.2018.12.11430591220
   PubMed Web of Science ®Google Scholar
• Zhang Z, Che X, Yang N, et al. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2. Biomed Pharmacother. 2017;96:1341–1348. doi:10.1016/j.biopha.2017.11.07429196101
   PubMed Web of Science ®Google Scholar
• Yang Y, Sun KK, Shen XJ, Wu XY, Li DC. miR-557 inhibits the proliferation and invasion of pancreatic cancer cells by targeting EGFR. Int J Clin Exp Pathol. 2019;12(4):1333–1341.31933947
   PubMed Web of Science ®Google Scholar
• Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4(1):199–227. doi:10.1146/annurev.pathol.4.110807.09222218817506
   PubMed Web of Science ®Google Scholar
• Sato H, Tamba M, Ishii T, Bannai S. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem. 1999;274(17):11455–11458. doi:10.1074/jbc.274.17.1145510206947
   PubMed Web of Science ®Google Scholar
• Bannai S. Transport of cystine and cysteine in mammalian cells. Biochim Biophys Acta. 1984;779(3):289–306. doi:10.1016/0304-4157(84)90014-56383474
   PubMed Web of Science ®Google Scholar
• Okuno S, Sato H, Kuriyama-Matsumura K, et al. Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines. Br J Cancer. 2003;88(6):951–956. doi:10.1038/sj.bjc.660078612644836
   PubMed Web of Science ®Google Scholar
• Liu -X-X, Li X-J, Zhang B, et al. MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11. FEBS Lett. 2011;585(9):1363–1367. doi:10.1016/j.febslet.2011.04.01821510944
   PubMed Web of Science ®Google Scholar
• Zhu J-H, De Mello RA, Yan Q-L, et al. MiR-139-5p/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K/Akt signaling pathway. Biochim Biophys Acta Mol Basis Dis. 2020;1866(6):165747. doi:10.1016/j.bbadis.2020.16574732109492
   PubMed Web of Science ®Google Scholar
• Shida D, Kanemitsu Y, Hamaguchi T, Shimada Y. Introducing the eighth edition of the tumor-node-metastasis classification as relevant to colorectal cancer, anal cancer and appendiceal cancer: a comparison study with the seventh edition of the tumor-node-metastasis and the Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma. Jpn J Clin Oncol. 2019;49(4):321–328.30608547
   PubMed Web of Science ®Google Scholar
• Cai X, Ding H, Liu Y, et al. Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer. Acta Biochim Biophys Sin (Shanghai). 2017;49(2):119–127.28069585
   PubMed Web of Science ®Google Scholar
• Jiang J, Li Z, Yu C, et al. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer. Cancer Lett. 2015;356(2):962–970. doi:10.1016/j.canlet.2014.11.00725444909
   PubMed Web of Science ®Google Scholar
• Jingyang Z, Jinhui C, Lu X, et al. Mir-320b inhibits pancreatic cancer cell proliferation by targeting FOXM1. Curr Pharm Biotechnol. 2020;27:100–109.
   Google Scholar
• Wang G, Kang M-X, Lu W-J, et al. MACC1: A potential molecule associated with pancreatic cancer metastasis and chemoresistance. Oncol Lett. 2012;4(4):783–791. doi:10.3892/ol.2012.78423205101
   PubMed Web of Science ®Google Scholar
• Patop IL, Kadener S. circRNAs in cancer. Curr Opin Genet Dev. 2018;48:121–127. doi:10.1016/j.gde.2017.11.00729245064
   PubMed Web of Science ®Google Scholar
• Vo JN, Cieslik M, Zhang Y, et al. The landscape of circular RNA in cancer. Cell. 2019;176(4):869–881. doi:10.1016/j.cell.2018.12.02130735636
   PubMed Web of Science ®Google Scholar
• Yang F, Liu D-Y, Guo J-T, et al. Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer. World J Gastroenterol. 2017;23(47):8345–8354. doi:10.3748/wjg.v23.i47.834529307994
   PubMed Web of Science ®Google Scholar
• Bi J, Liu H, Dong W, et al. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence. Mol Cancer. 2019;18(1):133. doi:10.1186/s12943-019-1060-931481066
   PubMed Web of Science ®Google Scholar
• Burris HA. Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway. Cancer Chemother Pharmacol. 2013;71(4):829–842. doi:10.1007/s00280-012-2043-323377372
   PubMed Web of Science ®Google Scholar
• Hassan B, Akcakanat A, Holder AM, Meric-Bernstam F. Targeting the PI3-kinase/Akt/mTOR signaling pathway. Surg Oncol Clin N Am. 2013;22(4):641–664. doi:10.1016/j.soc.2013.06.00824012393
   PubMed Web of Science ®Google Scholar
• Xu J-H, Wang Y, Xu D. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer. Cancer Biomarkers. 2019;25(2):193–201. doi:10.3233/CBM-18229331104012
   PubMed Web of Science ®Google Scholar
• Lv X, Li P, Wang J, et al. hsa_circ_0000520 influences herceptin resistance in gastric cancer cells through PI3K-Akt signaling pathway. J Clin Lab Anal. 2020;23:e23449.
   Google Scholar
• Qiu J, Hao Y, Huang S, et al. MiR-557 works as a tumor suppressor in human lung cancers by negatively regulating LEF1 expression. Tumour Biol. 2017;39(6):1010428317709467.28639890
   PubMedGoogle Scholar
• Wada T, Ishimoto T, Seishima R, et al. Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia. Cancer Sci. 2013;104(10):1323–1329.23848514
   PubMed Web of Science ®Google Scholar
• Drayton RM, Dudziec E, Peter S, et al. Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11. Clin Cancer Res. 2014;20(7):1990–2000.24516043
   PubMed Web of Science ®Google Scholar
• Huang Y, Dai Z, Barbacioru C, Sadée W. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Res. 2005;65(16):7446–7454.16103098
   PubMed Web of Science ®Google Scholar
• Savaskan NE, Heckel A, Hahnen E, et al. Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema. Nat Med. 2008;14(6):629–632.18469825
   PubMed Web of Science ®Google Scholar
• Wu Y, Sun X, Song B, Qiu X, Zhao J. MiR- 375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion. Cancer Med. 2017;6(7):1686–1697.28627030
   PubMed Web of Science ®Google Scholar